PRESS RELEASE published on 06/13/2024 at 20:35, 1 year 7 months ago Pathcore Announces Strategic Partnership With Instem to Enhance Digital Pathology Solutions for Toxicologic Pathology Workflows Pathcore Inc. announces strategic partnership with Instem, integrating Provantis preclinical data management solution with PathcoreFlow image management system to streamline digital pathology workflows for toxicopathology studies Digital Pathology Strategic Partnership Instem Pathcore Inc. Toxicopathology
PRESS RELEASE published on 06/13/2024 at 20:00, 1 year 7 months ago Digital Case Acceptance Platform Reports Record Data for Case Acceptance and Productivity After Months of Testing AcceptCare introduces new Payment Slider tool to boost high-value treatments like ortho, leading to significant increase in case acceptance rates and elective treatment production in dental practices Dental Practices Case Acceptance AcceptCare High-value Treatments Payment Slider
PRESS RELEASE published on 06/13/2024 at 19:48, 1 year 7 months ago Informations privilégiées / Autres communiqués ABIONYX Pharma a passé avec succès la réunion pré-IND avec la FDA pour une étude clinique de phase 2b/3 évaluant CER-001 dans le traitement de patients atteints de sepsis. La société se prépare à déposer une demande d’IND pour lancer l'étude clinique FDA ABIONYX Pharma Sepsis CER-001 Réunion Pré-IND
PRESS RELEASE published on 06/13/2024 at 19:48, 1 year 7 months ago Inside Information / Other news releases ABIONYX Pharma completes successful pre-IND meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial in Sepsis, marking significant progress in developing innovative therapy FDA ABIONYX Pharma Sepsis CER-001 Pre-IND Meeting
PRESS RELEASE published on 06/13/2024 at 19:35, 1 year 7 months ago GTT : Descriptif du programme de rachat d'actions Programme de rachat d'actions de GTT approuvé par l'assemblée générale mixte des actionnaires le 12 juin 2024. Objectifs, montant maximum des fonds et durée du programme détaillés Rachat D'actions Assemblée Générale Mixte GTT Autorisation Montant Maximum Des Fonds
PRESS RELEASE published on 06/13/2024 at 19:35, 1 year 7 months ago GTT : Main terms and conditions of the share buy-back programme GTT announces share buy-back programme with maximum purchase price of €190 per share and maximum amount of €704,488,650, allowing for various objectives including employee stock allocation and liquidity improvement Share Buy-back GTT Liquidity Improvement Maximum Purchase Price Employee Stock Allocation
PRESS RELEASE published on 06/13/2024 at 19:30, 1 year 7 months ago ThriveSparrow Launches Action Plans and AI-Driven Employee Sentiment Analysis to Enhance Employee Engagement ThriveSparrow launches Action Plans for enhanced employee feedback, leveraging AI for sentiment analysis and disrupting traditional performance reviews to boost engagement and performance AI-driven ThriveSparrow Employee Feedback Action Plans Performance Reviews
PRESS RELEASE published on 06/13/2024 at 19:30, 1 year 7 months ago SWTHZ (SweatHouz) Appoints Dr. Susanna Søberg, PhD as Lead Science and Education Advisor SWTHZ appoints Dr. Susanna Søberg, renowned in heat and cold therapy, to its Medical Advisory Board. Expansion plans include 100 new locations in 12 months Expansion Contrast Therapy SWTHZ Dr. Susanna Søberg Boutique Wellness
PRESS RELEASE published on 06/13/2024 at 19:23, 1 year 7 months ago GEVELOT S.A.: COMMUNIQUE MISE EN OEUVRE PROGRAMME RACHAT ACTIONS 2024 Gévelot S.A. met en œuvre un programme de rachat d'actions limité à 10 % du Capital, correspondant à 75 207 actions, avec un coût financier maximum de 18 000 K€. Objectif : rachat en vue d'annulation sur décision du Conseil d'Administration. Validité jusqu'au 13 décembre 2025 Rachat D'actions Conseil D'administration Programme GEVELOT S.A. Annulation
PRESS RELEASE published on 06/13/2024 at 19:23, 1 year 7 months ago GEVELOT S.A.: CGM 2024 PRESS RELEASE IMPLEMENTATION OF A SHARES BUY BACK PROGRAM GEVELOT SA's Board of Directors implements a share buyback program, authorizing the repurchase of shares for cancellation with specific financial limits until December 13, 2025 Capital Euronext Share Buyback Program GEVELOT SA Financial Cost
Published on 01/14/2026 at 08:05, 2 hours 22 minutes ago Tocvan Strengthens Board with Appointment of Anna Ladd-Kruger
Published on 01/14/2026 at 08:00, 2 hours 27 minutes ago Caledonia Mining Corporation Plc Change in Executive Management
Published on 01/14/2026 at 04:05, 6 hours 22 minutes ago Usha Resources and Totec Resources Announce TSXV Conditional Acceptance and Filing of Filing Statement for Qualifying Transaction
Published on 01/14/2026 at 09:35, 52 minutes ago Trident Accelerates European Home Textiles Expansion with Strategic Investments and New Collections
Published on 01/14/2026 at 09:30, 57 minutes ago Game District Passes 2.2 Billion Downloads Worldwide in 2025
Published on 01/14/2026 at 08:45, 1 hour 42 minutes ago Arnaud Lagardère appointed Non-Executive Chairman of Lagardère Travel Retail. Frédéric Chevalier succeeds Dag Rasmussen from March 1st 2026
Published on 01/14/2026 at 08:45, 1 hour 42 minutes ago Arnaud Lagardère appointed Non-Executive Chairman of Lagardère Travel Retail. Frédéric Chevalier succeeds Dag Rasmussen from March 1st, 2026
Published on 01/14/2026 at 08:45, 1 hour 42 minutes ago Arnaud Lagardère est nommé Président non exécutif de Lagardère Travel Retail. Frédéric Chevalier succède à Dag Rasmussen à compter du 1er mars 2026.
Published on 01/13/2026 at 18:27, 15 hours 59 minutes ago 260113 BENETEAU Déclaration du nombre d'actions et de droits de vote au 31-12-2025
Published on 01/13/2026 at 18:00, 16 hours 27 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 décembre 2025